Stanley-Laman Group, Ltd. - TRILLIUM THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 28 filers reported holding TRILLIUM THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
Quarter-by-quarter ownership
Stanley-Laman Group, Ltd. ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$809,000
-1.7%
139,403
+1.7%
0.20%
+7.6%
Q2 2018$823,000
+5.6%
137,091
+26.7%
0.18%
+4.5%
Q1 2018$779,000–108,184–0.18%–
 Download
Other shareholders

There were no reported owners of TRILLIUM THERAPEUTICS INC in Q2 2018.

NameSharesValueWeighting ↓
View complete list of TRILLIUM THERAPEUTICS INC shareholders